Genetic Inhibition of PCSK9 and Liver Function
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
JAMA cardiology - 6(2021), 3 vom: 01. März, Seite 353-354 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rimbert, Antoine [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 05.01.2022 Date Revised 05.01.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1001/jamacardio.2020.5341 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM317149113 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM317149113 | ||
| 003 | DE-627 | ||
| 005 | 20231225162631.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jamacardio.2020.5341 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1057.xml |
| 035 | |a (DE-627)NLM317149113 | ||
| 035 | |a (NLM)33146683 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rimbert, Antoine |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Genetic Inhibition of PCSK9 and Liver Function |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2022 | ||
| 500 | |a Date Revised 05.01.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a PCSK9 Inhibitors |2 NLM | |
| 650 | 7 | |a gamma-Glutamyltransferase |2 NLM | |
| 650 | 7 | |a EC 2.3.2.2 |2 NLM | |
| 650 | 7 | |a Aspartate Aminotransferases |2 NLM | |
| 650 | 7 | |a EC 2.6.1.1 |2 NLM | |
| 650 | 7 | |a Alanine Transaminase |2 NLM | |
| 650 | 7 | |a EC 2.6.1.2 |2 NLM | |
| 650 | 7 | |a PCSK9 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 650 | 7 | |a Proprotein Convertase 9 |2 NLM | |
| 650 | 7 | |a EC 3.4.21.- |2 NLM | |
| 700 | 1 | |a Smati, Sarra |e verfasserin |4 aut | |
| 700 | 1 | |a Dijk, Wieneke |e verfasserin |4 aut | |
| 700 | 1 | |a Le May, Cédric |e verfasserin |4 aut | |
| 700 | 1 | |a Cariou, Bertrand |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JAMA cardiology |d 2016 |g 6(2021), 3 vom: 01. März, Seite 353-354 |w (DE-627)NLM261792792 |x 2380-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2021 |g number:3 |g day:01 |g month:03 |g pages:353-354 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1001/jamacardio.2020.5341 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2021 |e 3 |b 01 |c 03 |h 353-354 | ||